0001962460-23-000001.txt : 20230120 0001962460-23-000001.hdr.sgml : 20230120 20230120172250 ACCESSION NUMBER: 0001962460-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230120 DATE AS OF CHANGE: 20230120 EFFECTIVENESS DATE: 20230120 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMORPHEX THERAPEUTICS HOLDINGS INC. CENTRAL INDEX KEY: 0001962460 IRS NUMBER: 873370764 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-471422 FILM NUMBER: 23541972 BUSINESS ADDRESS: STREET 1: 1 DUNDEE PARK STREET 2: SUITE 8 CITY: ANDOVER STATE: MA ZIP: 01810 BUSINESS PHONE: (978)244-4990 MAIL ADDRESS: STREET 1: 1 DUNDEE PARK STREET 2: SUITE 8 CITY: ANDOVER STATE: MA ZIP: 01810 D 1 primary_doc.xml X0708 D LIVE 0001962460 AMORPHEX THERAPEUTICS HOLDINGS INC. 1 DUNDEE PARK SUITE 8 ANDOVER MA MASSACHUSETTS 01810 (978)244-4990 DELAWARE None None Corporation true 2021 ROBERT THOMPSON 1 Dundee Park Suite 8 Andover MA MASSACHUSETTS 01810 Executive Officer Director CHIEF EXECUTIVE OFFICER Pharmaceuticals Decline to Disclose 06b false 2021-11-26 false true true false 5000 265000 265000 0 false 13 0 true 0 true 0 true false AMORPHEX THERAPEUTICS HOLDINGS INC. /s/ Robert Thompson Robert Thompson CHIEF EXECUTIVE OFFICER 2023-01-20